These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 28768163)
1. A protocol for quantitative analysis of murine and human amyloid-β Illouz T; Madar R; Griffioen K; Okun E J Neurosci Methods; 2017 Nov; 291():28-35. PubMed ID: 28768163 [TBL] [Abstract][Full Text] [Related]
2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
3. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Wang J; Dickson DW; Trojanowski JQ; Lee VM Exp Neurol; 1999 Aug; 158(2):328-37. PubMed ID: 10415140 [TBL] [Abstract][Full Text] [Related]
4. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains. Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613 [TBL] [Abstract][Full Text] [Related]
5. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242 [TBL] [Abstract][Full Text] [Related]
6. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
7. Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice. Rueda N; Vidal V; García-Cerro S; Narcís JO; Llorens-Martín M; Corrales A; Lantigua S; Iglesias M; Merino J; Merino R; Martínez-Cué C Brain Behav Immun; 2018 Oct; 73():235-251. PubMed ID: 29758264 [TBL] [Abstract][Full Text] [Related]
8. Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems. Jensen M; Hartmann T; Engvall B; Wang R; Uljon SN; Sennvik K; Näslund J; Muehlhauser F; Nordstedt C; Beyreuther K; Lannfelt L Mol Med; 2000 Apr; 6(4):291-302. PubMed ID: 10949910 [TBL] [Abstract][Full Text] [Related]
9. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease. Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978 [TBL] [Abstract][Full Text] [Related]
10. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. McGowan E; Pickford F; Kim J; Onstead L; Eriksen J; Yu C; Skipper L; Murphy MP; Beard J; Das P; Jansen K; DeLucia M; Lin WL; Dolios G; Wang R; Eckman CB; Dickson DW; Hutton M; Hardy J; Golde T Neuron; 2005 Jul; 47(2):191-199. PubMed ID: 16039562 [TBL] [Abstract][Full Text] [Related]
19. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease. Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102 [TBL] [Abstract][Full Text] [Related]
20. Risperidone ameliorated Aβ Wu L; Feng X; Li T; Sun B; Khan MZ; He L Behav Brain Res; 2017 Mar; 322(Pt A):145-156. PubMed ID: 28093254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]